コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 + monocytes expressed higher basal levels of heme oxygenase-1.
2 cyte anti-inflammatory heme-degrading enzyme heme oxygenase-1.
3 er two important molecules: nitric oxide and heme oxygenase-1.
4 f pathogenic CD8(+) T cells and induction of heme oxygenase-1.
5 n, the release of heme, and the induction of heme oxygenase-1.
6 l abrogated by pharmacological inhibition of heme oxygenase-1.
7 d on increased expression of the Nrf2 target heme oxygenase-1.
8 anced expression of glucose transporters and heme oxygenase-1.
9 nitric oxide synthase, cyclooxygenase-2, and heme oxygenase-1.
10 ement of NF-erythroid 2-related factor 2 and heme oxygenase-1.
11 p-regulation of the stress-inducible protein heme-oxygenase-1.
12 f Bcl-2 (5.5-folds), Bcl-xl (5.5-folds), and heme oxygenase-1 (4.4-folds); decreased expression of IC
13 ) mice have increased expression/activity of heme oxygenase-1, a phase II antioxidant, and NF (erythr
16 The carboxyhemoglobin level (a measure of heme oxygenase 1 activity) has not been assessed in adul
18 aimed to investigate the mechanisms by which heme oxygenase-1, an anti-inflammatory enzyme, is protec
19 , despite significantly higher expression of heme oxygenase-1, an antioxidant and cytoprotective enzy
21 orresponded with increases in cytoprotective heme oxygenase 1 and IL-10 mRNAs, selective reductions i
22 ential for linked antioxidant protection via heme oxygenase 1 and reduced foam cell formation via liv
23 ranofin displayed synergistic lethality with heme oxygenase-1 and glutamate-cysteine ligase inhibitor
25 e discuss here new insights into the role of heme oxygenase-1 and heme on cardiovascular health, and
26 ontractility rather than passive stretch via heme oxygenase-1 and histone deacetylase signalling.
28 d4 to Nrf2-binding sites on the promoters of heme oxygenase-1 and NADPH quinone oxidoreductase 1.
29 rf2 or DJ-1 attenuated Cu((II))ATSM-mediated heme oxygenase-1 and NADPH quinone oxidoreductase-1 indu
30 into the nucleus to induce transcription of heme oxygenase-1 and other cytoprotective enzymes throug
33 )S increased the expression of antioxidants (heme oxygenase-1 and thioredoxin 1), increased the expre
35 reverses vitamin C-induced up-regulation of heme-oxygenase-1 and ferritin in KRAS-mutant cancer cell
36 ples for hypoxia-inducible factor 1alpha and heme oxygenase 1, and 4) immunohistochemistry of hippoca
37 ntioxidant systems such as peroxiredoxins-1, heme oxygenase-1, and anti-apoptotic factors, including
38 ed anti-inflammatory factors interleukin-10, heme oxygenase-1, and Hsp70 in macrophages stimulated or
39 ing IL-1ra, IL-10, and PGE(2), but not IL-6, heme oxygenase-1, and NO, attenuated 5-FU-MSC-induced im
41 lation of the oxidative stress response gene heme oxygenase-1, and we demonstrated that NF-kappaB inh
42 evated levels of TNFalpha, reduced levels of heme-oxygenase-1, and display apparent signs of oxidativ
44 arkable cardioprotective effects ascribed to heme oxygenase-1 are best evidenced by its ability to re
46 le to upregulate the atheroprotective enzyme heme oxygenase-1 at the RNA and protein level in respons
47 ntrol animals, and inhibiting the HIF target heme-oxygenase-1 before IR reduced GFR in STN animals.
48 nhancing expression of the IL-10 target gene heme oxygenase-1 by mechanisms dependent on p38 MAPK act
49 lial NOS (eNOS), Nrf2, and Phase II enzymes (heme oxygenase-1, catalase, superoxide dismutase-1) in a
52 H(2)O(2), concomitant with up-regulation of heme oxygenase 1, COX-2, and anti-apoptotic proteins (BC
54 enhances its paracine effects on RIII via a heme oxygenase-1 dependent mechanism, which may help us
56 s, whereas treatment with carbon monoxide, a heme oxygenase-1 enzymatic product, abrogated this effec
57 als treated with tin protoporphyrin (SnPP, a heme oxygenase-1 enzyme inhibitor), even after Ad.Trx1 t
59 ion, hypoxia-inducible factor 1alpha-induced heme oxygenase 1 expression resulting in improved surviv
62 fects; JunB activated whereas JunD repressed heme oxygenase-1 expression in human renal epithelial ce
63 -induced oxidative stress by down-regulating heme oxygenase-1 expression via nuclear factor (erythroi
67 ncreased inducible nitric oxide synthase and heme-oxygenase 1 expression, and increased MDA and plasm
68 ncreased inducible nitric oxide synthase and heme-oxygenase 1 expression, and increased plasma creati
70 ation of the CBS inhibitor, CO, a product of heme oxygenase-1, flip the operating preference of CSE f
71 athione S-transferase (GST) genes as well as heme oxygenase 1 gene (HMOX1) encode enzymes that detoxi
72 med a systematic review and meta-analysis of heme oxygenase 1 gene (HO-1) promoter polymorphisms and
73 nosine thymidine dinucleotide repeats in the heme oxygenase-1 gene promoter in 386 patients with coro
74 nosine thymidine dinucleotide repeats in the heme oxygenase-1 gene promoter is associated with cardio
75 nosine thymidine dinucleotide repeats in the heme oxygenase-1 gene promoter is associated with higher
77 expression of Nrf2-dependent genes, such as heme oxygenase-1, glutamate-cysteine ligase catalytic su
79 f the azide complex of substrate-bound human heme oxygenase 1 (hHO) has been investigated by (1)H NMR
81 adenoassociated virus (rAAV)-encoding human heme oxygenase-1 (hHO-1) in attenuating post-ischemic in
83 the CX3CR1 receptor induced upregulation of heme-oxygenase-1 (HMOX-1), an antioxidant and anti-infla
84 talase, glutathione peroxidase 1 (GPX1), and heme oxygenase 1 (Hmox1) and transcription factor nuclea
86 We showed that variation in basal levels of heme oxygenase 1 (HMOX1) contribute to the response to O
87 ed reduced progesterone levels and placental heme oxygenase 1 (Hmox1) expression and increased methyl
89 nscriptional repressor, negatively regulates heme oxygenase 1 (HMOX1), a key cytoprotective enzyme th
90 h regulates the expression of genes encoding heme oxygenase 1 (Hmox1), glutamate-cysteine ligase cata
93 o prevent accumulation, the inducible enzyme heme oxygenase-1 (HMOX1) catalyzes degradation of heme.
94 n (HP), cluster of differentiation (CD) 163, heme oxygenase-1 (HMOX1), and biliverdin reductase A (BL
96 genes increased in the DKO liver, including heme oxygenase-1 (Hmox1), which disrupts complex III and
97 otective response relies on the induction of heme oxygenase-1 (HMOX1; HO-1) and ferritin H chain (FTH
98 em macrophages through coregulation of HO-1 (heme oxygenase-1; HMOX1) and lipid homeostasis genes.
99 ctivated protein (MAP) kinase, expression of heme oxygenase 1 (HO-1) and cyclooxygenase 2 (COX-2), an
100 ession of heat-shock protein 70 (HSP-70) and heme oxygenase 1 (HO-1) and promoted cell survival after
101 nd up-regulation of the antioxidant proteins heme oxygenase 1 (HO-1) and sulfiredoxin 1 (SRXN1).
103 re increases the stability of mRNAs encoding heme oxygenase 1 (HO-1) and TIEG-1 in human and mouse fi
105 ctor erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) gene proteins in retinal tissues
108 investigated whether up-regulation of DAF by heme oxygenase 1 (HO-1) is an underlying mechanism by us
110 e 2 signaling response, downstream of which, heme oxygenase 1 (HO-1) was also found to be time-depend
112 (hIL-10R) by cmvIL-10 led to upregulation of heme oxygenase 1 (HO-1), an enzyme linked with suppressi
113 ele contained less TNFalpha, MCP-1, and more heme oxygenase 1 (HO-1), and exhibited a higher rate of
114 overexpression of the heme-degrading enzyme, heme oxygenase 1 (HO-1), has been shown to protect mice
115 NAD(P)H:quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1), typical chemoprotective gene pr
117 on a key enzyme involved in heme catabolism, heme oxygenase 1 (HO-1), which, ironically, has been poo
123 per-zinc superoxide dismutase (CuZnSOD), and heme oxygenase-1 (HO-1) (antioxidant enzymes) were reduc
124 in 1 (P<0.05), peroxiredoxin 3 (P<0.01), and heme oxygenase-1 (HO-1) (P<0.05), which are up-regulated
127 f2, NAD(P)H quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1) and a high ratio of Bcl-2/Bax.
128 production of antioxidant enzymes, including heme oxygenase-1 (HO-1) and glutathione peroxidase 1 (Gp
129 of the antioxidant/anti-inflammatory enzyme heme oxygenase-1 (HO-1) and increased neuroinflammation
134 NA and protein levels of HIF-dependent genes heme oxygenase-1 (Ho-1) and manganese superoxide dismuta
135 nd to oxidative stress-induced expression of heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreducta
136 d CXCL8 secretion and required activation of heme oxygenase-1 (HO-1) and phosphorylated adenosine mon
137 cells by the regulations of novel molecules heme oxygenase-1 (HO-1) and programmed death-1 ligand 1
138 An ELISA assay for the Nrf2 target gene heme oxygenase-1 (HO-1) and studies using Nrf2 small int
139 a hypoxia-inducible plasmid expressing both heme oxygenase-1 (HO-1) and the Src homology domain-2 co
141 AC and selected reaction monitoring revealed heme oxygenase-1 (HO-1) as the most significantly up-reg
142 he cytoprotective and antiapoptotic molecule heme oxygenase-1 (HO-1) at the transcriptional level.
150 a, urine, and tissues, which in turn induces heme oxygenase-1 (HO-1) expression in the colonic epithe
152 vitro study showed that adiponectin induced heme oxygenase-1 (HO-1) expression through the peroxisom
154 ase expression, nitric oxide production, and heme oxygenase-1 (HO-1) expression, which was associated
156 al injury, and inhibited RPTC Nrf2, Agt, and heme oxygenase-1 (HO-1) gene expression in Akita Cat tra
163 lective overexpression of the stress protein heme oxygenase-1 (HO-1) in astrocytes of novel GFAP.HMOX
164 the products of the cytoprotective molecule heme oxygenase-1 (HO-1) in cancer cells, has been implic
165 of NO induce the anti-inflammatory effector heme oxygenase-1 (HO-1) in gastric epithelial cells thro
166 of the cytoprotective, heme-degrading enzyme heme oxygenase-1 (HO-1) in neutrophil progenitors in bon
167 e antioxidative and anti-inflammatory enzyme heme oxygenase-1 (HO-1) in the brains of individuals wit
168 ed a hypothesized anti-inflammatory role for heme oxygenase-1 (HO-1) in the development of metabolic
169 uanosine (8OHG), 4-hydroxynonenal (HNE), and heme oxygenase-1 (HO-1) in the pyramidal neurons of the
191 ion of host cell antioxidant enzymes such as heme oxygenase-1 (HO-1) may be useful therapeutically to
192 The stress-inducible cytoprotective enzyme heme oxygenase-1 (HO-1) may play a critical role in the
195 ukin-8 (IL-8), cyclooxygenase-2 (COX-2), and heme oxygenase-1 (HO-1) mRNA was measured in BEAS-2B cel
196 Treatment with CRA at nontoxic doses induced heme oxygenase-1 (HO-1) mRNA/protein expression and HO-1
197 of inducing the activity of the host enzyme heme oxygenase-1 (HO-1) on hRSV replication and pathogen
199 overexpression of the cytoprotective enzyme heme oxygenase-1 (HO-1) play a critical role in the grow
202 Only overexpression of the gene encoding heme oxygenase-1 (HO-1) significantly correlated with in
204 y amplified in human breast cancers, induced heme oxygenase-1 (HO-1) through Nrf2 transactivation in
206 gation revealed that the cytoprotective gene heme oxygenase-1 (HO-1) was induced in NF-kappaB-inhibit
207 erythroid 2p45-related factor-2 (Nrf2), and heme oxygenase-1 (HO-1) was tested in both in vitro and
208 up-regulation of the cytoprotective protein heme oxygenase-1 (HO-1) which is capable of mitigating a
209 amplification with pNaKtide and induction of heme oxygenase-1 (HO-1) with cobalt protoporphyrin (CoPP
210 d that PRRSV downregulates the expression of heme oxygenase-1 (HO-1), a pivotal cytoprotective enzyme
213 of oxidative stress caused by low levels of heme oxygenase-1 (HO-1), an important cytoprotective mol
215 ter antioxidant transcription factor, and of heme oxygenase-1 (HO-1), one of its main target genes, i
216 ome solid tumors and myeloid leukemia cells, heme oxygenase-1 (HO-1), the anti-oxidant, anti-inflamma
218 attention as a master protective sentinel is heme oxygenase-1 (HO-1), the rate-limiting step in the c
220 ported in a human patient and mice that lack heme oxygenase-1 (HO-1), we studied iron distribution an
221 Many cancer cells constitutively express heme oxygenase-1 (HO-1), which catabolizes heme to gener
222 is the up-regulation of the inducible enzyme heme oxygenase-1 (HO-1), which catabolizes heme to gener
223 Intracellular heme levels are regulated by heme oxygenase-1 (HO-1), which catalyzes the degradation
225 ng expression of the stress response protein heme oxygenase-1 (HO-1), which interacts with and thereb
226 ory functions, preclinical studies encourage heme oxygenase-1 (HO-1)-inducing regimens in clinical or
237 is generated by the stress-responsive enzyme heme oxygenase-1 (HO-1, encoded by Hmox1), which is high
239 n, protein levels, and enzymatic activity of heme oxygenase-1 (HO-1, the enzyme that produces CO), in
242 quality control is regulated in part by the heme oxygenase-1 (HO-1; Hmox1) system through the redox-
243 Q61L) mutant induced the anti-oxidant enzyme heme-oxygenase-1 (HO-1) through activation of NRF2.
246 kers (matrix metalloproteinase 1 [MMP-1] and heme oxygenase 1 [HO-1]), and proinflammatory cytokines
247 pha, monocyte chemoattractant-1 [MCP-1], and heme oxygenase-1 [HO-1]) was assessed by chromatin immun
250 ), intercellular adhesion molecule 1, IL-10, heme oxygenase 1 hypoxia-inducible factor 1 (HIF-1), mon
251 ssion of hypoxia-inducible factor 1alpha and heme oxygenase 1 in the hippocampus was increased in the
254 synthase derived) regulates the induction of heme oxygenase-1 in the lung, which in turn plays an imp
255 duced expression of the Nrf2 target protein, heme oxygenase-1 in the skin and protected against UVB-i
256 ge-like cell line RAW264.7, (b) induction of heme oxygenase-1 in these RAW cells, and (c) suppression
259 Cobalt protoporphyrin (CoPP), a well known heme oxygenase 1 inducer, has been used to promote endog
260 tor-kappaB, hypoxia-inducible factor-1alpha, heme oxygenase-1, inducible nitric oxide synthase, B-cel
262 vivo and IRAK-M(-/-) AECs in vitro with the heme oxygenase-1 inhibitor, tin protoporphyrin, substant
264 ction, by overcoming its negative regulator, heme oxygenase-1, is a key underlying mechanism responsi
265 a 7-day doxycycline treatment sustained high heme oxygenase-1 levels during the entire period of hypo
266 T6 recruits BAF170 to enhancer region of the Heme oxygenase-1 locus and promotes recruitment of RNA p
268 itochondrial superoxide dismutase (SOD), and heme oxygenase-1, mucosal receptors such as the Toll-lik
269 on of antioxidant genes, including those for heme oxygenase 1, NAD(P)H quinone oxidoreductase 1, and
270 e regulation of key Nrf2 target genes (i.e., heme oxygenase-1, NAD(P)H dehydrogenase, quinone 1, glut
271 ificantly upregulates Nrf2-responsive genes, heme oxygenase-1, NAD(P)H quinone oxidoreductase 1, and
272 most robustly increased genes and proteins, heme oxygenase 1, NADPH-quinone oxidoreductase 1, and gr
273 n and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and gl
274 such as superoxide dismutase, nitric oxide, heme oxygenase-1, neutrophil infiltration, cysteamine, m
275 -dependent gene and protein markers, such as heme oxygenase-1, occurred, whereas Nrf2-deficient fibro
278 es that impair liver regeneration, including heme oxygenase-1, programmed cell death 4, and the cycli
281 t upregulation of superoxide dismutase 2 and heme oxygenase 1 protein following hypoxia-reoxygenation
282 related with CO in the breath were levels of heme oxygenase-1 protein in serum and HMOX1 transcripts
283 , more importantly, amplified renoprotective heme-oxygenase-1 protein and mRNA expression in injured
284 mL; CO-E-CPR, 89 +/- 26 pg/mL; p < 0.05) and heme oxygenase-1 (sham, 1 +/- 0.1; cardiopulmonary resus
285 based proteomics screen, we identified HO-1 (heme oxygenase-1), the rate-limiting enzyme in the degra
286 c-Jun), and heat shock proteins (HSP-70 and heme oxygenase-1) to the HMGCR promoter and transcriptio
287 ced increases of nitric oxide synthase-2 and heme oxygenase-1 transcriptions were also inhibited by 7
288 ted bitransgenic mice that overexpress human heme oxygenase-1 under doxycycline control in an inducib
289 diac function are mediated via Akt-dependent heme oxygenase-1 up-regulation under those conditions.
292 myocardial overexpression of thioredoxin-1, heme oxygenase-1, vascular endothelial growth factor, an
295 ated protein 78), and the antioxidant enzyme heme oxygenase-1 were decreased, whereas levels of infla
296 tide phosphate:quinone oxidoreductase 1, and heme oxygenase-1 were lower in group 2 than group 3.
297 ioxidant enzymes peroxiredoxin-2 (Prdx2) and heme oxygenase-1 were upregulated in cd36-/- VSMCs.
298 pression levels of survival genes, Bcl-2 and heme oxygenase-1, were analyzed by gene array analysis a
299 ulation of H2A histone family, member X, and heme oxygenase 1, which were experimentally validated as
300 rdial nuclear factor E2-related factor 2 and heme-oxygenase 1 with a dietary supplement (Protandim) p